000 01468 a2200469 4500
005 20250516124804.0
264 0 _c20140211
008 201402s 0 0 eng d
022 _a1573-0646
024 7 _a10.1007/s10637-012-9909-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBorad, Mitesh J
245 0 0 _aEffect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials.
_h[electronic resource]
260 _bInvestigational new drugs
_cAug 2013
300 _a1056-65 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aClinical Trials, Phase I as Topic
650 0 4 _aElectrocardiography
650 0 4 _aFemale
650 0 4 _aHeart Rate
_xphysiology
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms
_xphysiopathology
650 0 4 _aPatient Selection
650 0 4 _aYoung Adult
700 1 _aSoman, Arundhati D
700 1 _aBenjamin, Martin
700 1 _aCasa, Daniel
700 1 _aTembe, Waibhav D
700 1 _aPiper, Barbara F
700 1 _aRamanathan, Ramesh
700 1 _aTibes, Raoul
700 1 _aJameson, Gayle
700 1 _aAnsaldo, Karen
700 1 _aVon Hoff, Daniel D
773 0 _tInvestigational new drugs
_gvol. 31
_gno. 4
_gp. 1056-65
856 4 0 _uhttps://doi.org/10.1007/s10637-012-9909-4
_zAvailable from publisher's website
999 _c22349008
_d22349008